The US Supreme Court on Monday declined to review a Fresenius Kabi USA LLC scientist’s claim that she faced discrimination ...
Fresenius Kabi's plant on Grand Island has a slogan: Saving lives one vial at a time. The plant, which employs about 800 people, makes sterile, injectable pharmaceuticals, used in doctors' offices ...
The European Commission has approved the first biosimilar version of Actemra/RoActemra, Roche’s $3 billion blockbuster, from German drugmaker Fresenius Kabi. The biosimilar of IL-6 inhibitor ...
The joint company will be 55% owned by Vifor Pharma and 45% by Fresenius Kabi. Fresenius Kabi will be fully responsible for the marketing of Vifor’s intravenous iron portfolio in China.
LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi, an operating company of Fresenius, and Formycon AG, a leading, independent developer of high-quality biosimilars, announced today that the ...